The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02066753 |
Recruitment Status :
Completed
First Posted : February 19, 2014
Last Update Posted : November 25, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This PhD study is a sub study in a randomized clinical controlled multicenter trial named "TTH48" (ClinicalTrials.gov Identifier: NCT01689077).
The TTH48 trial examines prolonged mild therapeutic hypothermia ("MTH") at 32-34°C in 24 versus 48 hours with the primary outcome Cerebral Performance Category after 6 month in comatose out-of-hospital cardiac arrest patients.
THE OVERALL AIM OF THIS PhD STUDY IS TO INVESTIGATE THE CARDIAC FUNCTION AND THE HEMODYNAMICS BY BIOCHEMICAL CARDIAC MARKERS, ECHOCARDIOGRAPHY, BY ANALYZING THE USAGE OF INOTROPES/VASOPRESSORS AND BY ANALYZING ECG DATA FOR ARRHYTHMIAS IN THE 24 VERSUS 48 HOURS MTH GROUPS.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cardiac Arrest Hypothermia | Procedure: Mild therapeutic hypothermia | Not Applicable |
The PhD-study contains 3 sub studies:
-
Study 1 estimates the extend of myocardial damage resulting from the primary arrest and from the reperfusion injuries: Area under the curve of cTnT and CK-MB as 12 repeated measurements and NT-proBNP as 4 measurements post arrest
-Hypothesis: There is a statistically significantly greater release of the cardiac biomarkers cTnT and NT-proBNP quantified by the area under the curve in the 24 versus the 48 hours group in the intervention period from 24 to 72 hours.
-
Study 2 investigates MTH´s influence on systolic and diastolic function by standard and Tissue Doppler (TDI) echocardiography after 24, 48 and 72 hours. The primary endpoint is mitral annular systolic velocity ("S´ max")
-Primary hypothesis: There is statistically significant improvement in S' max from the time T24 to T72 in the 48 versus the 24 hours group.
-Secondary hypothesis: There is statistically significantly better systolic function at T48 measured in terms of individual S' max-change in the 48 hours group (still hypothermic) versus the 24 hours group (reached normothermia).
-
Study 3 investigates MTH´s influence on the need for vasopressor or inotrope and the duration of arrhythmias during the first 72 hours post arrest.
- Primary hypothesis: There is a statistically significantly increased tendency of arrhythmias in the 48 versus the 24 hours group measured in the period from T0 to T72.
- Secondary hypothesis: There is a statistically significantly reduced need for inotropes in the 48 versus the 24 hours group measured by cumulative vasopressor index in the period from T0 to T72.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest |
Study Start Date : | February 2013 |
Actual Primary Completion Date : | November 2015 |
Actual Study Completion Date : | November 2015 |

Arm | Intervention/treatment |
---|---|
Active Comparator: 24 hours mild therapeutic hypothermia
The patient will be treated with mild therapeutic hypothermia for 24 hours after reaching the target temperature between 32-34°C.
|
Procedure: Mild therapeutic hypothermia
Mild therapeutic hypothermia with a target temperature between 32-34°C. |
Experimental: 48 hours mild therapeutic hypothermia
The patient will be treated with mild therapeutic hypothermia for 48 hours after reaching the target temperature between 32-34°C.
|
Procedure: Mild therapeutic hypothermia
Mild therapeutic hypothermia with a target temperature between 32-34°C. |
- Area under the curve cTnT [ Time Frame: In the intervention period from 24 to 72 hours ]Allocated sub study 1
- Mitral annular systolic velocity [ Time Frame: After 24 hours, 48 hours and 72 hours ]Allocated sub study 2
- Duration of arrhythmias [ Time Frame: From target temperature (32-34°C) has been reached until 72 hours after ]Allocated sub study 3
- Cumulative vasopressor index [ Time Frame: From target temperature (32-34°C) has been reached until 72 hours after ]Allocated sub study 3
- Area under the curve NT-proBNP [ Time Frame: In the intervention period from 24 to 72 hours ]Allocated sub study 1

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Resuscitated after cardiac arrest outside hospital with suspected cardiac triggering cause (and stabile circulation for at least 20 minutes after return of spontaneous circulation,
- Glasgow coma score < 8 and
- Age ≥ 18 years and < 80 years.
Exclusion Criteria:
- Cardiac arrest of suspected non-cardiac triggering cause (e.g. trauma, aortic dissection, massive bleeding, hypoxia or accidental hypothermia),
- >60 minutes from cardiac arrest to ROSC,
- Time from cardiac arrest until start of cooling >4 hours,
- Terminal illness,
- Coagulopathy (medical anticoagulation treatment including thrombolysis is not a contraindication),
- Unwitnessed arrests with asystolia as presenting rhythm,
- Pregnancy,
- Persistent cardiogenic shock,
- Systolic blood pressure <80 mmHg despite vasoactive treatment and intra-aortic balloon pump
- CPC 3-4 before the cardiac arrest,
- Suspected/confirmed acute intra cerebral hemorrhage or stroke,
- Acute CABG or other operation in connection with performing CPR,
- Lack of consent from the relatives,
- Lack of consent from the GP and
- Lack of consent from the patient if he/she wakes up and is relevant.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02066753
Denmark | |
Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Skejby | |
Aarhus N, Central Denmark Region, Denmark, 8200 | |
Norway | |
Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine, Stavanger University Hospital | |
Stavanger, Norway, 4068 |
Principal Investigator: | Anders Grejs, MD | Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Skejby, Denmark |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | University of Aarhus |
ClinicalTrials.gov Identifier: | NCT02066753 |
Other Study ID Numbers: |
TTH48AG |
First Posted: | February 19, 2014 Key Record Dates |
Last Update Posted: | November 25, 2015 |
Last Verified: | November 2015 |
Cardiac arrest Therapeutic Hypothermia Cardioprotectiveness Hemodynamics |
Heart Arrest Hypothermia Heart Diseases Cardiovascular Diseases Body Temperature Changes |